Top-News
Werbung

Attraktive Knock-Outs auf Qiagen NV

Typ Hebel Bid / Ask WKN
Call
5,0 0,76 € / 0,80 €
SW86TK
Call
9,8 0,38 € / 0,42 €
SU7NLL
Typ Hebel Bid / Ask WKN
Put
5,0 0,77 € / 0,81 €
SQ9S6G
Put
10,6 0,35 € / 0,39 €
SY0Q6H
Den Basisprospekt sowie endgültige Bedingungen und Basisinformationsblätter erhalten Sie bei Klick auf das Dokument-Icon. Beachten Sie auch die weiteren Hinweise zu dieser Werbung. Der Emittent ist berechtigt, Wertpapiere mit open end-Laufzeit zu kündigen.
Alle Knock-Outs auf Qiagen NV
Gesundheitswesen Niederlande

Qiagen NV News

Aktie
WKN:  A400D5 ISIN:  NL0015001WM6 US-Symbol:  QGEN
39,245 €
-0,105 €
-0,27%
29.05.24 21:59:02
Handeln Depot/Watchlist
Aktienanzahl *
228,04 Mio.
Marktkapitalisierung *
9,02 Mrd. €
Streubesitz
-
Index-Zugehörigkeit
TecDAX (Performance)
IR-Website
zur Website
*Stand: 05.02.2024
Weiter abwärts? Short handeln - Jetzt mit Hebel 18,12: ME7Z2Q

Unternehmensmeldungen

07.10.22 - DGAP
EQS-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Voting Rights Announcement: QIAGEN N.V. QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of ...
24.08.22 - DGAP
Finanzbericht: Qiagen N.V.: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß § 114, 115, 117 WpHG
DGAP Vorabbekanntmachung Finanzberichte: QIAGEN N.V. / Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten Qiagen N.V. ...
29.07.22 - DGAP
Zulassungsfolgepflichten: QIAGEN N.V.: Release of a capital market information
DGAP Post-​admission Duties announcement: QIAGEN N.V. / Form 6-K for the quarterly period ended June 30, 2022 QIAGEN N.V.: Release of a capital market information ...
08.06.22 - DGAP
Stimmrechtsanteile: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
DGAP Voting Rights Announcement: QIAGEN N.V. QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of ...
01.06.22 - DGAP
Stimmrechtsanteile: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
DGAP Voting Rights Announcement: QIAGEN N.V. QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of ...
01.06.22 - DGAP
Stimmrechtsanteile: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
DGAP Voting Rights Announcement: QIAGEN N.V. QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of ...
27.05.22 - DGAP
Stimmrechtsanteile: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
DGAP Voting Rights Announcement: QIAGEN N.V. QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of ...
27.05.22 - DGAP
Stimmrechtsanteile: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
DGAP Voting Rights Announcement: QIAGEN N.V. QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of ...
20.05.22 - DGAP
Stimmrechtsanteile: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
DGAP Voting Rights Announcement: QIAGEN N.V. QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of ...
29.04.22 - DGAP
Zulassungsfolgepflichten: QIAGEN N.V.: Release of a capital market information
DGAP Post-​admission Duties announcement: QIAGEN N.V. / Form 6-K for the quarterly period ended March 31, 2022 QIAGEN N.V.: Release of a capital market information ...
13.04.22 - DGAP
Finanzbericht: Qiagen N.V.: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß § 114, 115, 117 WpHG
DGAP Vorabbekanntmachung Finanzberichte: QIAGEN N.V. / Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten 13.04.2022 / 12:48 ...
05.04.22 - DGAP
Stimmrechtsanteile: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
DGAP Voting Rights Announcement: QIAGEN N.V. QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of ...
05.04.22 - DGAP
Stimmrechtsanteile: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
DGAP Voting Rights Announcement: QIAGEN N.V. QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of ...
30.03.22 - DGAP
Stimmrechtsanteile: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
DGAP Voting Rights Announcement: QIAGEN N.V. QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of ...
30.03.22 - DGAP
Stimmrechtsanteile: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
DGAP Voting Rights Announcement: QIAGEN N.V. QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of ...
25.03.22 - DGAP
Stimmrechtsanteile: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
DGAP Voting Rights Announcement: QIAGEN N.V. QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of ...
25.03.22 - DGAP
Stimmrechtsanteile: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
DGAP Voting Rights Announcement: QIAGEN N.V. QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of ...
18.03.22 - DGAP
Stimmrechtsanteile: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
DGAP Voting Rights Announcement: QIAGEN N.V. QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of ...
18.03.22 - DGAP
Stimmrechtsanteile: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
DGAP Voting Rights Announcement: QIAGEN N.V. QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of ...
14.03.22 - DGAP
Stimmrechtsanteile: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
DGAP Voting Rights Announcement: QIAGEN N.V. QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of ...

Newssuche

Videos

newspaper
29.05.24 -22,56%
Technical Trading: DAX Long Chance kurzfristig
DAX Long Typ: Turbo Open End WKN: VD5FWS Hebel: 28 Laufzeit: OpenEnd Einstieg: Market ... Mehr »
$logger->warn("fertig.m SKIPPED - kein Cookie"); # voruebergehend warn, nach Analyse auf Debug setzen